Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol for sedation in flexible bronchoscopy
NCT04211298Phase 4Unknown
- Sponsor
- Rabin Medical Center
- Start
- Dec 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine, sponsored by Rabin Medical Center. Primary endpoints: Number of de-saturation events and Oxygen saturation time < 90%. Status: unknown.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT04211298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04211298.